Comblike dendrimers containing Tn antigen modulate natural killing and induce the production of Tn specific antibodies

Journal of Medicinal Chemistry

Volumn 49, Issue 21, 2006, Pages 6400-6407

  Vepřek, Pavel ^a   Hajdúch, Marián ^b   Džubák, Petr ^b   Kuklík, Rostislav ^b   Poláková, Jana ^c   Bezouška, Karel ^c,d  

^a INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY   (Czech Republic)

^b PALACKÝ UNIVERSITY   (Czech Republic)

^c CHARLES UNIVERSITY   (Czech Republic)

^d INSTITUTE OF MICROBIOLOGY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD161 ANTIGEN; DENDRIMER; EPITOPE; GLYCOPEPTIDE; HAPTEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFLUENZA VIRUS HEMAGGLUTININ; LECTIN; NATURAL KILLER CELL RECEPTOR; PLANT LECTIN; TN ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG DISCRIMINATION; DRUG PROTEIN BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOGENICITY; IMMUNOMODULATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PHYSICAL CHEMISTRY; RAT; TUMOR CELL LINE;

2,4-DINITROPHENOL; ANIMALS; ANTIBODY FORMATION; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; CYSTEINE; CYTOTOXICITY, IMMUNOLOGIC; DENDRIMERS; EPITOPES; FEMALE; GLYCOPEPTIDES; HAPTENS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; JURKAT CELLS; KILLER CELLS, NATURAL; LECTINS; MICE; MICE, INBRED BALB C; PLANT LECTINS; PROTEIN BINDING; PROTEIN ISOFORMS; RATS; RECEPTORS, IMMUNOLOGIC; T-LYMPHOCYTES;

EID: 33750109163     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm050741g     Document Type: Article

References (42)

1. Byrd, J. C.; Bresalier, R. S. Mucins and mucin binding proteins in colorectal cancer. Cancer Metastasis Rev. 2004, 23, 77-99.
2. Hakomori, S. I. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res. 1996, 56, 5309-5318.
3. Toyokuni, T.; Singhal, A. K. Synthetic carbohydrate vaccines based on tumor-associated antigens. Chem. Soc. Rev. 1995, 24, 231-242.
4. Springer, G. F. T and Tn pancarcinoma markers: Autoantigenic adhesion molecules in pathogenesis, prebiopsy carcinoma-detection, and long-term breast carcinoma immunotherapy. Crit. Rev. Oncog. 1995, 6, 57-85.
5. Kumar, S. R.; Sauter, E. R.; Quinn, T. P.; Deutscher, S. L. Thomsen-Friedenreich and Tn antigens in nipple fluid: Carbohydrate biormarkers for breast cancer detection. Clin. Cancer Res. 2005, 11, 6868-6871.
6. Springer, G. F. T and Tn, general carcinoma auto-antigens. Science 1984, 224, 1198-1205.
7. O'Boyle, K. P.; Coatsworth, S.; Anthony, G.; Ramirez, M.; Greenwald, E.; Kaleya, R.; Steinberg, J. J.; Dutcher, J. P.; Wiernik, P. H. Effects of desialylation of ovine submaxillary gland mucin (OSM) on humoral and cellular immune responses to Tn and sialylated Tn. Cancer Immun. 2006, 6, 5-13.
8. Danishefsky, S. J.; Allen, J. R. From the Laboratory to the clinic: A retrospective on fully synthetic carbohydrate-based anticancer caccines. Angew. Chem., Int. Ed. 2000, 39, 836-863.
9. Sandmaier, B. M.; Oparin, D. V.; Holmberg, L. A.; Reddish, M. A.; MacLean, G. D.; Longenecker, B. M. Evidence of a cellular immune response against sialyl-Tn in breast and ovarian cancer patients after high-dose chemotherapy, stem cell rescue, and immunization with theratope STn-KLH cancer vaccine. J. Immunother. 1999, 22, 54-66.
10. Kunz, H.; Birnbach, S. Synthesis of O-glycopeptides of the tumor-associated Tn- and T-antigen type and their binding to bovine serum albumin. Angew. Chem., Int. Ed. Engl. 1986, 25, 360-362.
11. Freire, T.; Lo-Man, R.; Piller, F.; Piller, V.; Leclerc, C.; Bay, S. Enzymatic large-scale synthesis of MUC6-Tn glycoconjugates for antitumor vaccination. Glycobiology 2006, 16, 390-401.
12. Buskas, T.; Ingale, S.; Boons, G. J. Towards a fully synthetic carbohydrate-based anticancer vaccine: Synthesis and immunological evaluation of a lipidated glycopeptide containing the tumor-associated Tn antigen. Angew. Chem., Int. Ed. 2005, 44, 5985-5988.
13. Veprek, P.; Jezek, J. Peptide and glycopeptide dendrimers. Part I. J. Pept. Sci. 1999, 5, 5-23.
14. Tam, J. P.; Yu, Q.; Miao, Z. Orthogonal ligation strategies for peptide and protein. Biopolymers 1999, 51, 311-332.
15. Langenhan, J. M.; Thorson, J. S. Recent Carbohydrate-based chemoselective ligation applications. Curr. Org. Synth. 2005, 2, 59-81.
16. Niederhafner, P.; Sebestik, J.; Jezek, J. Peptide dendrimers. J. Pept. Sci. 2005, 11, 757-788.
17. Kagan, E.; Ragupathi, G.; Yi, S. S.; Reis, C. A.; Gildersleeve, J.; Kahne, D.; Clausen, H.; Danishefsky, S. J.; Livingston, P. O. Comparison of antigen constructs and carrier molecules for augmenting the immunogenicity of the monosaccharide epithelial cancer antigen Tn. Cancer Immunol. Immunother. 2005, 54, 424-430.
18. Nefzi, A.; Sun, X. C.; Mutter, M. Chemoselective ligation of multifunctional peptides to topological templates via thioether formation for TASP synthesis. Tetrahedron Lett. 1995, 36, 229-230.
19. Berd, D.; Sato, T.; Maguire, H. C.; Kairys, J.; Mastrangelo, M. J. Immunopharmacologic analysis of human autologous hapten-modified human melanoma vaccine. J. Clin. Oncol. 2004, 22, 403-415.
20. Lamb, J. R.; Eckels, D. D.; Lake, P.; Woody, J. N.; Green, N. Human T-cell clones recognize chemically synthesized peptides of influenza hemagglutinin. Nature 1982, 300, 66-69.
21. B. simplicifolia. binding affinity for α-D-Gal (major affinity), α-D-GalNAc (secondary affinity); C. fragile, binding affinity for α-n-GalNAc (Tn) at the terminal reducing or nonreducing end; D. biflorus. binding affinity for α-D-GalNAc (Tn) at the terminal nonreducing end; V. villosa B4, binding affinity for α-D-GalNAc at the terminal reducing end.
22. Rohlenova, A.; Ledvina, M.; Saman, D.; Bezouska, K. Synthesis of linear and branched regioisomeric chitooligosaccharides as potential mimetics of natural oligosaccharide ligands of natural killer cells NKR-P1 and CD69 lectin receptors. Collect. Czech. Chem. Commun. 2004, 69, 1781-1804.
23. Vannucci, L.; Fiserova, A.; Sadalapure, K.; Lindhorst, T. K.; Kuldova, M.; Rossmann, P.; Horvath, O.; Kren, V.; Krist, P.; Bezouska, K.; Luptovcova, M.; Mosca, F.; Pospisil, M. Effects of N-acetyl-glucosamine-coated glycodendrimers as biological modulators in the B16F10 melanoma model in vivo. Int. J. Oncol. 2003, 23, 285-96.
24. Bezouska, K.; Vlahas, G.; Horvath, O.; Jinochova, G.; Fiserova, A.; Giorda, R.; Chambers, W. H.; Feizi, T.; Pospisil, M. Rat natural-killer-cell antigen, NKR-P1, related to C-type animal lectins is a carbohydrate-binding protein. J. Biol. Chem. 1994, 269, 16945-16952.
25. Wu, A. M.; Song, S. C.; Chang, S. C.; Wu, J. H.; Chang, K. S. S.; Kabat, E. A. Further characterization of the binding properties of a GalNAc specific lectin from Codium fragile subspecies tomentosoides. Glycobiology 1997, 7, 1061-1066.
26. Wu, A. M.; Song, S. C.; Hwang, P. Y.; Wu, J. H.; Chang, K. S. S. Binding-studies on the combining site of a GalNAcaα1→specific lectin with Thomsen-Friedenreich activity prepared from green marine-algae Codium fragile subspecies tomentosoides. Eur. J. Biochem. 1995, 233, 145-151.
27. Osinaga, E.; Bay, S.; Tello, D.; Pritsch, O.; Assemat, K.; Cantacuzene, D.; Nakada, H.; Alzari, P. Analysis of the fine specificity of Tn-binding proteins using synthetic glycopeptide epitopes and biosensor based on surface plasmon resonance spectroscopy. FEBS Lett. 2000, 469, 24-28.
28. Plihal, O.; Byrtusova, P.; Pavlicek, J.; Mihok, L.; Ettrich, R.; Man, P.; Pompach, P.; Havlicek, V.; Husakova, L.; Bezouska, K. The isoforms of rat natural killer cell receptor NKR-PI display a distinct binding of complex saccharide ligands. Collect. Czech. Chem. Commun. 2004, 69, 631-644.
29. Nakada, H.; Numata, Y.; Inoue, M.; Tanaka, N.; Kitagawa, H.; Funakoshi, I.; Fukui, S.; Yamashina, I. Elucidation of an essential structure recognized by an anti-GalNAc-aplha-Ser}Thr] monoclonal antibody (MLS-128). J. Biol. Chem. 1991, 266, 12402-12405.
30. Peri, F.; Cipolla, L.; Rescigno, M.; La Ferla, B.; Nicotra, F. Synthesis and biological evaluation of an anticancer vaccine containing the C-glycoside analogue of the Tn epitope. Bioconjugate Chem. 2001, 12, 325-328.
31. Sojka, D. K.; Felnerova, D.; Mokyr, M. B. Anti-metastatic activity of hapten-modified autologous tumor cell vaccine in an animal tumor model. Cancer Immunol. Immunother. 2002, 51, 200-208.
32. Lisbonne, M.; Diem, S.; Keller, A. D.; Lefort, J.; Araujo, L. M.; Hachem, P.; Fourneau, J. M.; Sidobre, S.; Kronenberg, M.; Taniguchi, M.; Van Endert, P.; Dy, M.; Askenase, P.; Russo, M.; Vargaftig, B. B.; Herbelin, A.; Leite-de-Moraes, M. C. Cutting edge: Invariant V alpha 14 NKT cells dare required for allergen-induced airway inflammation and hyperreactivity in an experimental asthma model. J. Immunol. 2003, 171, 1637-1641.
33. Dombrowitz, D. Exploiting the innate immune system to control allergic asthma. Eur. J. Immunol. 2005, 35, 2786-2788.
34. Osinaga, E.; Pancico, G.; Porchet, N.; Mistro, D.; Aubert, J. P.; Roseto, A. Analysis of the carcinoma-associated epitope defined by monoclonal antibody 83D4. Breast Cancer Res. Treat. 1994, 32, 139-152.
35. Toyokuni, T.; Hakomori, S.; Singhal, A. K. Synthetic carbohydrate vaccines: Synthesis and immunogenicity of Tn antigen conjugates. Bioorg. Med. Chem. 1994, 2, 1119-1132.
36. Ellman, G. L. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 1959, 82, 70-77.
37. Harlow, E.; Lane, D. Antibodies: A Laboratory Manual; Cold Spring Harbor Laboratory Press: Plainview, NY, 1998.
38. Slovin, S. F.; Raguapathi, G.; Adluri, S.; Ungers, G.; Terry, K.; Kim, S.; Spassova, M.; Bornmann, W. G.; Fazzari, M.; Dantis, L.; Olkiewicz, K.; Lloyd, K. O.; Livingston, P. O.; Danishefsky, S. J.; Scher, H. I. Carbohydrate vaccines in cancer: Immunogenicity of a fully synthetic globo hexasaccharide conjugate in man. Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 5710-5715.
39. Ragupathi, G.; Slovin, S. F.; Adluri, S.; Sames, D.; Kim, I. J.; Kim, H. M.; Spassova, M.; Bornmann, W. G.; Lloyd, K. O.; Scher, H. I.; Livingston, P. O.; Danishefsky, S. J. A fuly synthetic globo H carbohydrate vaccine induces a focused humoral response to prostate cancer patients: A proof of principle. Angew. Chem., Int. Ed. 1999, 38, 563-566.
40. Bezouska, K.; Yuen, C.-T.; O'Brien, J.; Childs, R. A.; Chai, W.; Lawson, A. M.; Drbal, K.; Fiscaronerova, A.; Pospisil, M.; Feizi, T. Oligosaccharide ligands for NKR-P1 protein activate NK cells and cytotoxicity. Nature 1994, 372, 150-157.
41. Slovin, S. F.; Ragupathi, G.; Adluri, S.; Ungers, G.; Terry, K.; Kim, S.; Spassova, M.; Bornmann, W. G.; Fazzari, M.; Dantis, L.; Olkiewicz, K.; Lloyd, K. O.; Livingston, P. O.; Danishefsky, S. J.; Scher, H. I. Carbohydrate vaccines in cancer: Immunogenicity of a fully synthetic globo H hexasaccharide conjugate in man. Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 5710-5715.
42. Inoue, M.; Nakada, H.; Tanaka, N.; Yamashina, I. Tn antigen is expressed on leukosialin from T-lymphoid cells. Cancer Res. 1994, 54, 85-88.